Skip to main content
$112.64 -$0.82 (-0.7%)

10:59 AM EDT on 06/01/23

Alexandria Real Estate Equities, Inc. (NYSE:ARE)

CAPS Rating: 4 out of 5

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Current Price $112.64 Mkt Cap $19.6B
Open $112.58 P/E Ratio 25.02
Prev. Close $113.46 Div. (Yield) $4.78 (4.2%)
Daily Range $110.88 - $112.92 Volume 88,885
52-Wk Range $110.64 - $172.65 Avg. Daily Vol. 1,235,659

Caps

How do you think NYSE:ARE will perform against the market?

Add Stock to CAPS Watchlist

All Players

103 Outperform
53 Underperform
 

All-Star Players

18 Outperform
8 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ARE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SanFranFan (< 20)
Submitted June 24, 2022

I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.

Ewok82 (27.48)
Submitted May 25, 2009

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

Recent Community Commentary

Read the most recent pitches from players about ARE.

Recs

1
Member Avatar SanFranFan (< 20) Submitted: 6/24/2022 2:03:00 AM : Outperform Start Price: $136.83 NYSE:ARE Score: -27.71

I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.

Recs

1
Member Avatar BrentonKJ (20.74) Submitted: 6/23/2022 12:32:53 PM : Outperform Start Price: $127.10 NYSE:ARE Score: -26.32

Growth reit in healthcare

Recs

0
Member Avatar RowdyCat (52.24) Submitted: 2/9/2020 11:40:48 AM : Outperform Start Price: $157.43 NYSE:ARE Score: -55.03

This pick gets exposure to the biotech/pharma industries without investment in a specific company. Rather, ARE is a REIT that builds out laboratory space for up and coming companies.

Leaderboard

Find the members with the highest scoring picks in ARE.

Score Leader

TrackJMP

TrackJMP (< 20) Score: +238.61

The Score Leader is the player with the highest score across all their picks in ARE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Macademia 90.16 1/20/2009 Underperform 1Y $37.49 +198.92% +405.11% +206.19 2 Comments
brgr1 75.94 8/27/2008 Underperform 1Y $67.93 +64.97% +238.17% +173.20 0 Comment
mamabourne 96.34 8/7/2008 Underperform 3M $68.59 +63.40% +236.30% +172.90 0 Comment
ScreenerStizBear 47.13 6/27/2008 Underperform NS $63.07 +77.70% +235.95% +158.25 1 Comment
Camel2414 < 20 6/12/2008 Underperform 3M $63.94 +75.28% +221.62% +146.34 0 Comment
itsoeasy 79.00 4/24/2008 Underperform NS $65.84 +70.22% +215.79% +145.56 0 Comment
bilderberger < 20 3/17/2008 Underperform 3Y $55.64 +101.41% +244.22% +142.81 3 Comments
loudoungroup < 20 12/17/2008 Underperform NS $33.44 +235.13% +374.24% +139.11 0 Comment
Jesse500v 92.40 5/5/2008 Underperform 3W $66.45 +68.65% +207.37% +138.72 0 Comment
mongievic 92.63 11/19/2008 Underperform NS $31.22 +258.95% +396.47% +137.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARE.